238 related articles for article (PubMed ID: 34752487)
21. Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing.
Chooi WH; Chin JS; Chew SY
Methods Mol Biol; 2021; 2211():183-191. PubMed ID: 33336278
[TBL] [Abstract][Full Text] [Related]
22. Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified sgRNAs.
Holmgaard AB; Askou AL; Jensen EG; Alsing S; Bak RO; Mikkelsen JG; Corydon TJ
Mol Ther; 2021 Jan; 29(1):191-207. PubMed ID: 33022212
[TBL] [Abstract][Full Text] [Related]
23. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
Bai B; Myklebust JH; Wälchli S
Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
[TBL] [Abstract][Full Text] [Related]
24. Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.
Rathbone T; Ates I; Fernando L; Addlestone E; Lee CM; Richards VP; Cottle RN
CRISPR J; 2022 Jun; 5(3):397-409. PubMed ID: 35238624
[TBL] [Abstract][Full Text] [Related]
25. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
Campbell LA; Richie CT; Maggirwar NS; Harvey BK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
[TBL] [Abstract][Full Text] [Related]
26. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
27. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing
Hamada T; Yokoyama S; Akahane T; Matsuo K; Tanimoto A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613947
[TBL] [Abstract][Full Text] [Related]
28. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
Naeem M; Majeed S; Hoque MZ; Ahmad I
Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
[TBL] [Abstract][Full Text] [Related]
29. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
Kim H; Choi J; Won KH
BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
[TBL] [Abstract][Full Text] [Related]
30. Non-viral delivery of the CRISPR/Cas system: DNA
Lin Y; Wagner E; Lächelt U
Biomater Sci; 2022 Mar; 10(5):1166-1192. PubMed ID: 35103261
[TBL] [Abstract][Full Text] [Related]
31. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
Zhang S; Shen J; Li D; Cheng Y
Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
[TBL] [Abstract][Full Text] [Related]
32. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes.
Camperi J; Moshref M; Dai L; Lee HY
Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212
[TBL] [Abstract][Full Text] [Related]
33. Cell-free protein synthesis of CRISPR ribonucleoproteins (RNP).
McGaw C; Chong S
Methods Enzymol; 2021; 659():371-389. PubMed ID: 34752296
[TBL] [Abstract][Full Text] [Related]
34. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
Bruntraeger M; Byrne M; Long K; Bassett AR
Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
[TBL] [Abstract][Full Text] [Related]
35. Lipofection-Based Delivery of CRISPR/Cas9 Ribonucleoprotein for Gene Editing in Male Germline Stem Cells.
Obermeier M; Rogiers V; Vanhaecke T; Baert Y
Methods Mol Biol; 2024; 2770():123-134. PubMed ID: 38351451
[TBL] [Abstract][Full Text] [Related]
36. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887
[TBL] [Abstract][Full Text] [Related]
38. Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
Andersson M; Turesson H; Olsson N; Fält AS; Ohlsson P; Gonzalez MN; Samuelsson M; Hofvander P
Physiol Plant; 2018 Dec; 164(4):378-384. PubMed ID: 29572864
[TBL] [Abstract][Full Text] [Related]
39. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs.
Laustsen A; Bak RO
Methods Mol Biol; 2019; 1961():127-134. PubMed ID: 30912044
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct.
Kim S; Jeong YK; Cho CS; Lee S; Sohn CH; Kim JH; Jeong Y; Jo DH; Bae S; Lee H
Adv Healthc Mater; 2023 Feb; 12(4):e2201825. PubMed ID: 36326169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]